All posts by imreal

Science: Biology

Cambridge Semantics Garners Acclaim Across Over 25 Gartner Reports in 2023!

Leave a comment


More and more enterprises are starting to understand the importance and power of deploying a data fabric architecture and Gartner, as well as other thought leaders, are taking notice. Here at Cambridge Semantics, we believe the key enablers for a data fabric are knowledge graphs powered by our uniquely scalable graph database in conjunction with our semantics-driven approach. Semantics is key as it transcends the challenges of compartmentalized metadata and terminology into a single view. “Data and analytics leaders need to adopt a semantic approach to their enterprise data to drive business value and break data silos.” Adopt a Data Semantics Approach to Drive Business Value.

So far, Cambridge Semantics has been named in 29 reports from Gartner in 2023. These reports cover a plethora of different industries and concepts, highlighting how transferable and valuable the technology has become. Cambridge Semantics’ Anzo platform is used by customers in Life Sciences, Manufacturing, Financial Services, and many more verticals, so request a custom demo today to learn how Anzo can help your organization.

The majority of these reports should be available to Gartner subscribers. If you would like visibility into any of these reports, reach out and we will do our best to get it into your hands.

Reports:

Hype Cycles:

Media Contact

Jon Zuanich, Cambridge Semantics, 6172450517, [email protected], https://cambridgesemantics.com/

Twitter

SOURCE Cambridge Semantics



Health

An Innovative Solution to Tackling the Escalating US Drug Crisis

Leave a comment


In the U.S., the drug pandemic claims over 300 lives daily, prompting experts to redefine the crisis’s nature. Synthetic opioids infiltrate the market, camouflaged as legitimate medications, leading to a devastating impact, particularly among young people.

InterOme, a frontrunner in public health, champions its advanced solution “PULSE.” This user-friendly digital health platform leverages real-time data analysis, amalgamating individual, public, and asset health data into a centralized geospatial database. Its power lies in monitoring drug trends through anonymous wastewater analysis, revolutionizing drug exposure assessment.

The whitepaper addresses the gravity of the drug crisis and introduces the PULSE platform as a potent weapon against drug poisoning. Developed with Brevi-T Bio, InterOme’s wastewater drug monitoring service offers empirical evidence to accurately gauge drug usage, enabling informed decision-making while maintaining individual privacy.

PULSE showcases technology’s might in combating public health crises, unveiling patterns, predicting trends, and empowering authorities with actionable insights. The newly established non-profit, “Hopeful Life,” amplifies impact through interdisciplinary collaboration.

As the drug crisis persists, the whitepaper asserts real-time, accurate information coupled with proactive interventions can bring meaningful change. The collaboration between InterOme, Brevi-T Bio and Hopeful Life reflects a commitment to saving lives and communities. In pursuit of a safer tomorrow, the white paper’s insights mark a critical stride forward.

For more information visit www.hopefullife.org.

To download the full press release, please visit www.brevitbio.com or www.interome.com

Media Contact
Corina Shtir, InterOme, 1 858-294-0204, [email protected], www.interome.com

SOURCE InterOme

Health

Bioprocess Validation Market to grow by USD 280.93 million from 2022 to 2027 | Agilent Technnologies Inc., Avantor Inc., and Corning Inc., are some of the market key players – Technavio

Leave a comment



NEW YORK, Aug. 31, 2023 /PRNewswire/ — The bioprocess validation market is set to grow by USD 280.93 million from 2022 to 2027. However, the growth momentum will progress at a CAGR of 11.39% during the forecast period, according to Technavio. The bioprocess validation market is…

Science: Biology

Number 1 Solar Eclipse Glasses Manufacturer American Paper Optics launches “Get Eclipsed!” Back-to-School Education Campaign

Leave a comment


APO CEO/Founder John Jerit says , “With over 32 million people living in the “Path of Totality” for the North American Eclipse (April 8, 2024), which is three times more than the 2017 Total Solar Eclipse, the time is now to educate everyone on the “Ring of Fire” Annular Eclipse (October 14, 2023), that will serve as the ‘warm up act for the 2024 Total Solar Eclipse’. We don’t want people to miss out on the record-breaking 2024 eclipse because there won’t be another one like it until 2045.”

American Paper Optics’ Safe Solar Eclipse Glasses are ISO Certified, “NASA selected”, and Made in the USA. APO was chosen by NASA to manufacture their custom branded Eclipse Glasses in various styles. After a successful campaign with NASA in 2017, APO was once again picked to manufacture their safe solar glasses for the upcoming eclipses in 2023 and 2024. These Eclipser™ glasses will be distributed via their public outreach programs to build awareness for these upcoming events.

The “Get Eclipsed!” Education Campaign tools will include:

1.    APO’s “NASA Selected” Eclipse Safe Solar Glasses
2.    “Get Eclipsed” book by Fred Espenak
3.    Fun Facts about the 2 Upcoming Eclipses
4.    Exclusive Bill Nye The Science Guy safe solar eclipse glasses
5.    Solar Snap –The Eclipse App – developed by Astronomer Doug Duncan, who worked on Hubble Space Telescope
6.    Graphic Novel “The Moonies – Journey to The Total Solar Eclipse” by Meg Jerit and Illustrated by Tamar Blaauw
7.    Moon Pies
8.    Monthly Eclipse 101 Webinars
9.    EclipseGlasses.com website
10.    Social Media campaign
11.    FAQs with eclipse viewing safety tips
12.    Media Interviews and More

To get up-to-speed quickly, anyone can read American Paper Optics’ book, “Get Eclipsed” that comes with two safe solar eclipse glasses. The book was written specifically for these two eclipse events by Fred Espenak, a retired astrophysicist from NASA’s Goddard Space Flight Center, and his wife Patricia Totten Espenak, a retired science teacher, whose traveled widely with Fred to view celestial events. Readers can find maps and charts with the “Path of Annularity” (Oct 14, 2023) and “Path of Totality” (April 8, 2024) details, “Eclipse Magnitude” in your city, and eclipse times in major cities across the US, Canada and Mexico.

The October 14, 2023, Annular Solar Eclipse will be a partial eclipse that will be able to be seen all over the United States. The “Path of Annularity” will provide the best views in parts of Oregon, Nevada, Utah, Arizona, New Mexico, Texas and Mexico’s Yucatan peninsula. Cities such as Medford, Eugene, Albuquerque, Sante Fe, San Antonio and Corpus Christi will provide the best views of what is known as the “Ring of Fire”.

For the April 8, 2024, Total Solar Eclipse, Jason Lewin APO CMO adds, “88% of Americans watched the total eclipse in 2017 and the April 8, 2024, total eclipse is going to be even bigger. For this ‘Super Bowl of the Sky’, the ‘Path of Totality’ will cross 13 States, with millions of people having already made travel plans.” Lewin, emphasizes, “While this is set to be an historic moment, we want to make sure that everyone is preparing accordingly. Take the day off, have a plan and make sure your glasses are MADE IN THE USA!”

Major cities for the April 8, 2024, Total Solar Eclipse, including Austin, Dallas, Indianapolis, Cleveland, Buffalo, Rochester, and Montreal will experience “total darkness”, as long as the weather cooperates.

For more information on these 2023/2024 eclipse events, APO’s safe solar eclipse glasses and their one-stop shop for eclipse needs, visit https://EclipseGlasses.com.

And follow @americanpaperoptics3d on Instagram to find 2023 and 2024 eclipse daily updates.

MEDIA CONTACT for interviews with American Paper Optics
Liz Kelly, 310-987-7207

Media Contact

Liz Kelly, PR for American Paper Optics, 310-987-7207, [email protected], https://www.eclipseglasses.com/

SOURCE American Paper Optics

Health: Addiction

Slone Partners Places Christophe Arbet-Engels as Chief Medical Officer at X4 Pharmaceuticals

Leave a comment


“Dr. Arbet-Engels is a highly respected and experienced global pharmaceutical executive with keen business acumen honed over more than 20 years serving in complex organizational settings,” said Leslie Loveless, Slone Partners CEO. “We are very pleased to have been able to place him at X4 where we believe his extraordinary drive, passion, and vision – and his proven track record of success – will make a wonderful addition to the company’s leadership team.”

“It was truly a pleasure collaborating with Slone Partners on the placement of Christophe as our new Chief Medical Officer,” said Paula Ragan, Ph.D., President and Chief Executive Officer of X4 Pharmaceuticals, “We very much value our relationship with the Slone team and consider them a valuable ongoing resource to X4 given their deep understanding of and high quality connections within the life science industry.”

ABOUT SLONE PARTNERS
Slone Partners delivers the leaders who build amazing and diverse life sciences and healthcare organizations – People Are Our Science®. Founded in 2000, Slone Partners specializes in delivering world-class C-suite leadership, executive, and upper management talent to the most promising and established biotech, diagnostics, research tools, healthcare, precision medicine, medical device, and laboratory services companies. With national and global clients, Slone Partners uniquely and precisely provides an array of executive search and advisory services, including diversity, equity, and inclusion strategy, to innovative life sciences and healthcare companies. To learn more about Slone Partners’ value proposition and processes, visit http://www.slonepartners.com or call 888.784.3422.

Media Contact

Doug Gavel, Doug Gavel Communications, (617) 429-4417, [email protected], www.douggavel.com

SOURCE Slone Partners

Science: Biology

Armexa Names New Vice President John Cusimano to Leadership Team

Leave a comment


Cusimano comes to Armexa from one of the Big 4 consulting firms where he served as managing director for the company’s Cyber OT and IoT organization, working with Fortune 500 multinational companies. An accomplished business and thought leader, he has more than 30 years of experience in process control, functional safety, OT and industrial cybersecurity.

“I believe the OT cybersecurity industry is at an inflection point. A lot of resources have been spent over the last decade conducting OT cybersecurity assessments and installing OT detection systems, which is great because we now have a better understanding of OT cyber risk and visibility into our OT assets,” Cusimano said. “However, I think it’s time to shift our focus to implementing the recommendations from assessments, remediating the high-risk vulnerabilities discovered by detection tools, and to start truly realizing the value of the investments made in OT security technology.”

Cusimano is a voting member of the ISA99 cybersecurity standards committee, through which he chaired the subcommittee that authored the ISA/IEC 62443-3-2:2020 standard “IACS Security Risk Assessment & Design.” Before he joined the major consulting firm, Cusimano started up and led two successful ICS/OT cybersecurity consulting practices.

“I joined Armexa because I wanted to get back to my roots of leading a dedicated team of industrial cybersecurity experts who are laser-focused on helping companies of all sizes mitigate their OT cybersecurity risk,” he said.

Cusimano will share his industry knowledge and insights on the most recent update to TSA’s Security Directive at the GPA Midstream Convention on Sept. 18 during the Pipeline Safety Forum. He will also present on OT cybersecurity program development at the API Cybersecurity Conference & Expo on Nov. 8.

“Our company is young, but within we’ve housed decades of OT security experience,” Marzloff said. “By adding John’s expertise, passion for the industry and commitment to excellence, we’ve further bolstered our position as a top choice for OT security solutions for industrial operations.”

To learn more about building and growing an OT security program, visit Armexa.com.

Armexa, an industrial cybersecurity company, is a team of dedicated operational technology (OT) cybersecurity experts with decades of hands-on experience working in gas plants, refineries, pipelines, manufacturing facilities and offshore facilities to help those operations run safely, reliably and securely. Armexa helps organizations build and commission OT cybersecurity programs that align with industry regulations, standards, and companies’ existing IT security policies and standards. Visit Armexa.com to learn more.

Media Contact

Crystal Myers, Armexa, 1 832-762-3550, [email protected], https://armexa.com/

SOURCE Armexa